Wyeth must pay a group of generic drug companies for the harm they suffered after the drug maker won interlocutory injunctions blocking their plans to market an extended release generic version of anti-depressant Effexor, in a ruling likely to have a chilling effect on interlocutory injunction grants in pharmaceutical patent cases.
ASIC has been given a little over a month to provide ANZ with documents it collected during the course of its investigation into a $2.5 billion ANZ share placement, as the bank, which is facing a related criminal cartel case, mulls whether to file an application to stay the regulator’s action.
Woolworths has shot back at claims in a shareholder class action that it breached its continuous disclosure obligations, saying the lawsuit doesn’t allege there was material information it should have disclosed to shareholders in advance of its downward revision of a 2015 profit guidance.
Former Solicitor-General Justin Gleeson, SC, told a Federal Court judge Wednesday to reject a proposed $35 million deal between ASIC and Westpac, saying the bank should pay at least $100 million if it committed the responsible lending breaches alleged by the regulator.
Swedish air conditioner supplier Dometic has lost is case alleging patent infringement claims against Australian rivals Houghton Leisure and Finch Australia over the popular Belaire 3200 AC used in caravans and other recreational vehicles.
Liquidators for the collapsed Hastie Group will pursue test cases against two construction companies in their legal fight against more than two dozen major builders over tens of millions of dollars in unpaid bills, but an application is looming to halt the proceedings pending the outcome of a High Court challenge.
The New South Wales transportation regulator in charge of the Sydney light rail project says contractor Acciona Infrastructure is delaying a lawsuit over $1.2 billion in fees for the project by repeatedly ignoring requests for pleadings.
Generic drug company Apotex has settled a patent infringement case brought by global pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro.
Japanese car parts manufacturer Yazaki will have to pay a $46 million penalty for price-fixing, now that the High Court has refused to hear its appeal of the record competition fine.
The Commonwealth of Australia has resolved its claims against pharmaceutical giant Wyeth over the price it paid to list Effexor on the PBS, months after a high stakes trial wrapped up.